KMDA Kamada Ltd.

6.85
0  -1%
Previous Close 6.90
Open 7.00
Price To book 3.77
Market Cap 249.67M
Shares 36,448,000
Volume 3,391
Short Ratio 1.49
Av. Daily Volume 9,631

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2 initiated April 2016
Alpha-1 antitrypsin (AAT)
Prevention of lung transplant rejection
PDUFA date August 29, 2017.
KamRAB
Prophylaxis of rabies disease
Top-line data released August 30, 2016. Primary endpoint met. Pivotal trial planned.
Inhaled formulation of AAT
AATD - Alpha-1 Antitrypsin deficiency
Phase 2/3 data due mid-2017.
Alpha-1 Antitrypsin (AAT)
Pediatric patients newly diagnosed with type 1 diabetes
Announced November 2, 2016 that Phase 2/3 enrollment to start imminently with data due 2020.
Alpha-1 antitrypsin (AAT)
Graft Versus Host Disease (GvHD)

Latest News

  1. Kamada Ltd. :KMDA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 10, 2017
  2. Kamada to Host R&D Day Focused on Graft versus Host Disease (GvHD)
  3. Kamada Announces Collaboration with Massachusetts General Hospital for Proof of Concept Study Evaluating Benefit of Liquid Alpha-1 Antitrypsin on Liver Preservation Prior to Transplantation
  4. Kamada Ltd. :KMDA-US: Earnings Analysis: 2016 By the Numbers : February 9, 2017
  5. Kamada Announces Appointment of Biopharmaceutical Industry Veteran, Gwen Melincoff, to its Board of Directors
  6. Kamada reports 4Q loss
  7. Kamada Reports Financial Results for the Fourth Quarter and Full-Year 2016
  8. Kamada to Host Fiscal Year 2016 Financial Results Conference Call on February 6
  9. ETFs with exposure to Kamada Ltd. : January 20, 2017
  10. Puma (PBYI) Expands Study Cohort for Lead Candidate PB272
  11. Evoke Diabetic Gastroparesis Drug Gimoti Positive in Phase III
  12. Allergan (AGN) Liletta sNDA Accepted for Review in the U.S.
  13. Allergan Natrelle Inspira Breast Implants Approved in the U.S.
  14. ETFs with exposure to Kamada Ltd. : December 14, 2016
  15. Kamada Ltd. :KMDA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 28, 2016
  16. Can Agilent Technologies (A) Pull a Surprise in Q4 Earnings?
  17. Kamada (KMDA) Extends Partnership with Shire for Glassia